Skip to Main Content

Fiscal Year 2025 Competitive Grant Program Announced!

Now Accepting Applications

Maryland’s Office of Overdose Response is pleased to announce our Competitive Grant Program for fiscal year 2025! The purpose of our Competitive Grant Program is to distribute funding to the highest-scoring proposals received from state and local governments, as well as from private and not-for-profit community-based partners, that align with Maryland’s strategic priorities and serve to meet some of the greatest needs around the State. The funding available for our Competitive Grant Program is approximately $6 million. 

Eligibility & Requirements

The following entities are eligible to apply:
  1. state agencies;
  2. local government entities (including local school systems); and
  3. private and not-for-profit community-based partners.
    • Must be a Maryland partners benefitting Maryland residents *Recovery residences must admit consumers who are receiving Medications for Opioid Use Disorder (MOUD) in order to be considered for funding.
All project proposals must address the overdose crisis via Prevention, Harm Reduction, Treatment, Recovery, and Public Safety. Additionally, funding will be prioritized for projects that fall within our priority projects.

How to Apply

The application deadline for FY 25 proposals is Friday, March 1, 2024, at 5 p.m. EDT. Interested parties should review the Request for Proposals. The document includes key dates, application process, evaluation standards, funding specifications, reporting requirements, and other information to complete the application process.  Please contact Khalil Cutair at Khalil.Cutair@Maryland.gov with further questions. All applications should be submitted via this Smartsheet form

Relevant Materials

Key Dates

  • Call for Proposal Release Date: Friday, January 9, 2024
  • Information Session: Friday, February 9, 2024 (1–2 pm)
  • Application Deadline: Friday, March 1, 2024
  • Award Decisions: Friday, May 31, 2024 (Tentative)
  • Anticipated Period of Performance: July 1, 2024 – June 30, 2025

Information Session: Friday, February 9, 2024 (virtual)

This information session was held on Friday, February 9, 2024 to provide an overview of the application process and requirements for our fiscal year 2025 Competitive Grant Program. Information Session Agenda
    • Program Overview
    • Strategic Priorities/Priority Projects
    • How to Apply
    • Evaluation Process & Scoring Criteria

Meeting Recording | Meeting Materials

Block Grant Program (Fiscal Year 2024)

Maryland’s Office of Overdose Response is distributing $4 million through our Block Grant Program in the 2024 fiscal year. This program helps to ensure that all of Maryland’s 24 local jurisdictions receive a base level of funding to support overdose-related programs and initiatives. The program also takes into account local impacts of the opioid crisis and distributes half of the funds proportionally based on overdose mortality rates. These funds are distributed directly to local jurisdictions and will be administered by local health departments.

The full list of FY 2024 block grant awards is available here.

Competitive Grant Program (Fiscal Year 2024)

The purpose of our Competitive Grant Program is to distribute grant funding to the highest-scoring proposals received from state and local governments and community-based partners that serve to address unmet and urgent overdose-related needs around the state. Maryland’s Office of Overdose Response is distributing approximately $6 million through this program in the 2024 fiscal year.

The full list of FY 2024 competitive grant awards is available here.

Examination and Treatment Act Grant Program

Maryland’s Office of Overdose Response is distributing approximately $7.8 million in grant awards to support local jurisdictions in implementing the requirements of the Opioid Use Disorder Examination and Treatment Act (ETA) of 2019. These requirements include screening incarcerated individuals for opioid use disorder (OUD), offering peer recovery specialist services, counseling services to develop re-entry plans for individuals upon release, and offering all three FDA-approved formulations of medications for opioid use disorder (MOUD), such as methadone or buprenorphine, in all local detention facilities in Maryland.

The grant awards will support projects in 16 local detention facilities, a summary of which can be found here.

Stay in Contact!

To receive notifications regarding future funding opportunities, please complete the following form to be added to our mailing list.

Mailing List Sign-Up Form

doit-GOCIWP-w01